New insight into pain mechanisms

(Medical Xpress) -- Researchers in the UCL Wolfson Institute for Biomedical Research have made a discovery which could help the development of analgesic drugs able to treat nerve damage-related pain.

The research is published today in the journal Nature Communications and funded by the Biotechnology and Biological Sciences Research Council (BBSRC).

Current work well for some types of pain, but are not very effective for easing the chronic pain associated with . This type of pain is called neuropathic pain and it is associated with diseases like or trauma.

New findings from Professor John Wood (UCL Wolfson Institute for Biomedical Research) could help change this. They have identified the specific in mice that are important for transmitting particular types of pain and that the transmission of neuropathic pain is dependent on a specific pain-signalling channel called Nav1.7.

Professor Wood and his team studied mice in which Nav1.7 is lost and were able to demonstrate that mice without the Nav 1.7 channel did not suffer from neuropathic pain. This suggests it could be a for drugs to treat neuropathic pain.

The research also improves our understanding of the role of the Nav1.7 channel in the release of transmitters that cause pain sensations and suggested that new pain killers may work best if they can be directed both to the ends of the nerves in the skin and to the .

While it was already known that the loss of this Nav 1.7 channel in humans stops the experience of acute and , such as that caused by a cut or a burn, or a long term condition like arthritis, this is the first research to show a connection with neuropathic pain. It provides important clues for the development of effective new Nav1.7-targeted pain killers.

Professor John Wood, said: “Chronic pain is debilitating, but not all pain is bad pain. For example, if we touch a scalding saucepan, acute pain makes us withdraw our hand. What we are trying to do is to find targets for drugs which mean chronic pain can be alleviated, while enabling our body to still respond to other types of acute pain that protect us. ”

This research highlights the crucial role of fundamental bioscience in providing new knowledge to pave the way for the production of new pharmaceuticals.

add to favorites email to friend print save as pdf

Related Stories

Chronic pain gene identified

Sep 08, 2011

British researchers say they have identified the gene that controls chronic pain, opening the door to new drug therapies that block the chemical processes that cause chronic back pain, headaches or arthritis.

Switch off enzyme to control chronic pain, say researchers

Jan 12, 2011

A team of researchers at the University of Toronto has developed a new drug targeted at parts of the brain and spinal cord associated with pain perception, which may more effectively control chronic pain caused by nerve injuries.

Protein found that may provide relief from neuropathic pain

Dec 05, 2007

Neuropathic pain is caused by injury to the peripheral nerves in diseases such as HIV/AIDS, shingles, and cancer or in repetitive motion disorders and trauma, and does not respond well to conventional pain-relieving drugs.

Recommended for you

Connection found between birth size and brain disorders

7 hours ago

(Medical Xpress)—A trio of researchers has found what appears to be a clear connection between birth size and weight, and the two brain disorders, autism and schizophrenia. In their paper published in Proceedings of ...

A novel therapy for sepsis?

Sep 16, 2014

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

User comments